Grauer & Weil India growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024
+4.5%+6.9%+8.0%
+4.4%+0.3%+21.9%
+3.9%−0.7%+24.4%
+6.5%+9.0%+28.7%
+6.6%+8.8%−35.6%
+12.5%+14.3%+17.9%
+6.1%−8.2%+39.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GRAUWEIL₹82.12

Grauer & Weil India Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASINDOKEMJYOTIRESKANCHIMcap ₹3,722 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue Growth—+8.0+6.9+4.5
EBITDA Growth—+21.9+0.3+4.4
EBIT Growth—+24.4-0.7+3.9
Net Income Growth—+28.7+9.0+6.5
EPS Growth—-35.6+8.8+6.6
Total Assets Growth—+17.9+14.3+12.5
Cash from Operations Growth—+39.8-8.2+6.1
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.